RecruitingNCT02149004

German Centre for Infection Research HIV Translational Platform

Translational Research Platform of the TTU HIV of the German Center for Infection Research (DZIF)


Sponsor

University Hospital of Cologne

Enrollment

10,000 participants

Start Date

Apr 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

Despite major advances in therapy and management, HIV/AIDS continues to be a major cause of infectious disease morbidity and mortality on a global scale. The discovery of effective antiretroviral treatment has turned HIV infection into a manageable chronic disease in most patients with access to care. However, the different economic and epidemiologic situation in developing and developed countries requires different research priorities, so that three main challanges are universal and in focus of research of the DZIF HIV Translational Platform: * Prevention of HIV infection * Long-term life with HIV * HIV cure The "Translation Reserach HIV" will bring together clinical researchers in HIV infection in order to develop new treatment options to the above mentioned main challanges. It will take advantage of existing expertise (e.g. basic science, novel targets for treatment and HIV eradiation) of the partner sites. This platform is necessary because Germany's HIV research has suffered in the past from a lack of integration between its excellent basic science and clinical research. In addition, there was too little integration into networks that address the main international challenges. There is an urgent need to link these research strands through dedicated structures emphasising the translation of preclinical results into new therapies.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • HIV positive

Exclusion Criteria1

  • None

Locations(1)

University Hospital of Cologne

Cologne, North Rhine-Westphalia, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02149004


Related Trials